Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992744 · ClinicalTrials.gov registry record
BDNF Pregnancy Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 32
- Enrollment target
NCT01992744: Completed study, sponsored by University of Pennsylvania.
NCT01992744 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992744 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the correlation between varying levels of neuropeptides and birth outcomes. Neuropeptides are substances (proteins) produced in the body in very small amounts but without which the nervous system cannot function properly, and which might have a role in the health of a newborn. As part of this study, we are collecting blood samples from pregnant women. Neuropeptides and hormones can be measured in blood. This study will involve three blood draws from the participants arm. Demographic information will also be requested, and participants will be asked to complete questionnaires about their mood and personal experiences at each visit. Our hypothesis is that participants with lower levels of brain-derived neurotrophic factor (BDNF) will be at increased risk for poor birth outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992744
The ClinicalTrials.gov registry entry for NCT01992744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01992744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992744 about?
NCT01992744 is a clinical study titled "BDNF Pregnancy Study". The purpose of this study is to evaluate the correlation between varying levels of neuropeptides and birth outcomes. Neuropeptides are substances (proteins) produced in the body in very small amounts but without which the nervous system cannot function properly, and which might have a role in the he...
What is the current status of trial NCT01992744?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2012-05. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01992744?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.